Liraglutide (API – CAS 204656-20-2)

Overview Liraglutide is a synthetic peptide that belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class. It is primarily used in the management of weight and is indicated for patients with obesity or overweight conditions. As a bulk pharmaceutical-grade active pharmaceutical ingredient (API), Liraglutide is manufactured under stringent quality controls in India, ensuring compliance with international standards. Therapeutic Application Liraglutide plays a crucial role in the therapeutic management of obesity and related metabolic conditions. It functions by mimicking the effects of the GLP-1 hormone, which helps to regulate appetite and food intake. This API is commonly utilized in various formulations aimed at weight management, making it an essential component for pharmaceutical manufacturers targeting these therapeutic areas. Specifications The specifications for Liraglutide are as follows: CAS Number: 204656-20-2 Appearance: White to off-white powder Typical Assay/Purity: ≥99.0% Common Pharmacopeial Grades: USP, EP, BP, IP Storage: Store in a cool, dry place, away from light Shelf Life: Typically 24 months when stored properly Regulatory & Compliance Pharmint Exports adheres to WHO-GMP manufacturing standards, ensuring that Liraglutide is produced in compliance with global quality requirements. Regulatory documentation such as Certificate of Analysis (COA) and Certificate of Suitability (COS) are available upon inquiry. While we do not claim specific regulatory filings, our commitment to quality and compliance is paramount in meeting the needs of our clients in regulated markets including the USA, EU, Canada, and Australia. Packaging & Shipping Liraglutide is packaged in 25kg HDPE drums with double LDPE liners to ensure product integrity during transit. The drums are palletized for safe shipping, and all necessary export documentation is provided. We ensure that our logistics meet the requirements for timely delivery to the listed markets. Common Use Cases & Finished Dosage Forms Liraglutide is utilized in various dosage forms, including: Tablets Capsules Injections This flexibility in formulation allows pharmaceutical companies to incorporate Liraglutide into a range of therapeutic products aimed at weight management and related conditions. Ordering Information Minimum Order Quantity (MOQ) is subject to inquiry. For pricing, Certificate of Analysis (COA), and further information, please request a quote via this listing. You may also contact Pharmint Exports directly for assistance with your order.